Roughly two in five people newly ill with TB worldwide are never diagnosed. In South Africa, this amounts to about 120 000 to 160 000 people per year. A large new study called XACT III is testing ways in which more people can be diagnosed and started on TB treatment more quickly. Tiyese Jeranji reports.
Treating highly drug-resistant forms of tuberculosis can take anything from nine to 24 months and patients have to contend with various unpleasant, and sometimes dangerous, side effects. A new six-month regimen made up of just three drugs that will be offered to 400 patients in South Africa might offer a better solution for some. Tiyese Jeranji reports.
A study published in the Lancet medical journal confirms that the health effects of COVID-19 can linger months after someone has ‘recovered’. Kathryn Cleary asked local experts about the underlying science and whether the South African public healthcare system is ready for so-called long-COVID.
At Cape Town’s Tygerberg Hospital, a robot named Quintin played its part in the fight to save Nceba Simayile’s life as he lay intubated on a ventilator, struggling to breathe. Biénne Huisman reports.
People with COVID-19 and people with tuberculosis (TB) can experience similar symptoms such as coughing and breathing difficulties as both diseases affect the lungs. Exactly how these diseases affect the lungs, however, differs. Tiyese Jeranji spoke to a leading South African pulmonologist to learn more.